Cover Image
close this bookPharmaceuticals and the WTO TRIPS Agreement: Questions and answers (UNAIDS - WHO/EDM, 2000, 5 p.)
View the document(introductory text...)
View the documentAcknowledgements
View the documentWhat is TRIPS?
View the documentWhat will change with TRIPS?
View the documentWhen does TRIPS apply?
View the documentWhich drugs will be affected by the new patent rules?
View the documentWhat are developing countries' obligations under TRIPS?
View the documentFurther reading

Acknowledgements

The authors are very grateful to Dr J.D. Quick (WHO/EDM) and Dr M. Scholtz (WHO/HTP) for their constructive comments. Professor C.M. Correa (University of Buenos Aires), Mr A. Otten (WTO), Mr R. Wilder (WIPO) and Ms S. Zarilli (UNCTAD) are also acknowledged for their technical review and contributions to the document.

The views expressed in this document by named authors are solely the responsibility of those authors.

Suggestions and comments are welcome and should be sent to medmail@who.int

This document is not a formal publication of either UNAIDS or WHO, and all rights are reserved by the organizations. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes.